{
    "Trade/Device Name(s)": [
        "BinaxNOW\u00ae PBP2a Test",
        "BinaxNOW\u00ae PBP2a",
        "Binax NOW\u00ae PBP2a Test",
        "Binax NOW\u00ae PBP2a",
        "NOW\u00ae PBP2a Test",
        "NOW\u00ae PBP2a"
    ],
    "Submitter Information": "Binax, Inc.",
    "510(k) Number": "K090301",
    "Predicate Device Reference 510(k) Number(s)": [
        "K850291",
        "K011710"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "MYI"
    ],
    "Summary Letter Date": "March 29, 2010",
    "Summary Letter Received Date": "March 31, 2010",
    "Submission Date": "April 12, 2010",
    "Regulation Number(s)": [
        "21CFR866.1640"
    ],
    "Regulation Name(s)": [
        "Methicillin Resistant Staphylococcus aureus (MRSA)"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Penicillin-binding protein 2a (PBP2a)"
    ],
    "Specimen Type(s)": [
        "Blood culture (positive for Staphylococcus aureus)"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Immunochromatographic assay"
    ],
    "Methodologies": [
        "Qualitative immunochromatographic membrane assay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay"
    ],
    "Document Summary": "FDA 510(k) summary for BinaxNOW PBP2a rapid immunochromatographic test detecting PBP2a protein in blood cultures positive for Staphylococcus aureus to identify MRSA.",
    "Indications for Use Summary": "Qualitative, in vitro immunochromatographic assay for rapid detection of penicillin-binding protein 2a (PBP2a) in methicillin-resistant Staphylococcus aureus (MRSA) from blood cultures positive for S. aureus; not intended for diagnosis, treatment guidance, or monitoring of MRSA infections.",
    "fda_folder": "Microbiology"
}